237 related articles for article (PubMed ID: 25728022)
41. Synthesis and in vitro antitumor activity of new series of benzothiazole and pyrimido[2,1-b]benzothiazole derivatives.
Gabr MT; El-Gohary NS; El-Bendary ER; El-Kerdawy MM
Eur J Med Chem; 2014 Oct; 85():576-92. PubMed ID: 25127150
[TBL] [Abstract][Full Text] [Related]
42. Discovery of 4-aminoquinazoline--urea derivatives as Aurora kinase inhibitors with antiproliferative activity.
Cai J; Li L; Hong KH; Wu X; Chen J; Wang P; Cao M; Zong X; Ji M
Bioorg Med Chem; 2014 Nov; 22(21):5813-23. PubMed ID: 25270403
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and anticancer activities of novel 8-azapurine carbocyclic nucleoside hydrazones.
Wang Y; Yan H; Ma C; Lu D
Bioorg Med Chem Lett; 2015 Oct; 25(20):4461-3. PubMed ID: 26364944
[TBL] [Abstract][Full Text] [Related]
44. Effective synthesis of benzimidazoles-imidazo[1,2-a]pyrazine conjugates: A comparative study of mono-and bis-benzimidazoles for antitumor activity.
Singh I; Luxami V; Paul K
Eur J Med Chem; 2019 Oct; 180():546-561. PubMed ID: 31344614
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, characterization and biological evaluation of some 16β-azolyl-3β-amino-5α-androstane derivatives as potential anticancer agents.
Guo H; Zhang G; Zhang T; He X; Wu Z; Xiao Y; Pan Y; Qiu G; Liu P; Hu X
Eur J Med Chem; 2011 Sep; 46(9):3662-74. PubMed ID: 21641694
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
Singh M; Tandon V
Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and antiproliferative activity of 6-phenylaminopurines.
Canela MD; Liekens S; Camarasa MJ; Priego EM; Pérez-Pérez MJ
Eur J Med Chem; 2014 Nov; 87():421-8. PubMed ID: 25282265
[TBL] [Abstract][Full Text] [Related]
48. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.
Hranjec M; Starčević K; Pavelić SK; Lučin P; Pavelić K; Karminski Zamola G
Eur J Med Chem; 2011 Jun; 46(6):2274-9. PubMed ID: 21439689
[TBL] [Abstract][Full Text] [Related]
51. Lignopurines: a new family of hybrids between cyclolignans and purines. Synthesis and biological evaluation.
Castro MÁ; Miguel del Corral JM; García PA; Rojo MV; Bento AC; Mollinedo F; Francesch AM; San Feliciano A
Eur J Med Chem; 2012 Dec; 58():377-89. PubMed ID: 23153810
[TBL] [Abstract][Full Text] [Related]
52. Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
Romero-Parra J; Mella-Raipán J; Palmieri V; Allarà M; Torres MJ; Pessoa-Mahana H; Iturriaga-Vásquez P; Escobar R; Faúndez M; Di Marzo V; Pessoa-Mahana CD
Eur J Med Chem; 2016 Nov; 124():17-35. PubMed ID: 27560280
[TBL] [Abstract][Full Text] [Related]
53. Facile identification of dual FLT3-Aurora A inhibitors: a computer-guided drug design approach.
Chang Hsu Y; Ke YY; Shiao HY; Lee CC; Lin WH; Chen CH; Yen KJ; Hsu JT; Chang C; Hsieh HP
ChemMedChem; 2014 May; 9(5):953-61. PubMed ID: 24665000
[TBL] [Abstract][Full Text] [Related]
54. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study.
Al-Suwaidan IA; Alanazi AM; Abdel-Aziz AA; Mohamed MA; El-Azab AS
Bioorg Med Chem Lett; 2013 Jul; 23(13):3935-41. PubMed ID: 23683592
[TBL] [Abstract][Full Text] [Related]
55. Synthesis of benzimidazoles bearing oxadiazole nucleus as anticancer agents.
Rashid M; Husain A; Mishra R
Eur J Med Chem; 2012 Aug; 54():855-66. PubMed ID: 22608854
[TBL] [Abstract][Full Text] [Related]
56. Cancer stem cells CD133 inhibition and cytotoxicity of certain 3-phenylthiazolo[3,2-a]benzimidazoles: design, direct synthesis, crystal study and in vitro biological evaluation.
Al-Ansary GH; Eldehna WM; Ghabbour HA; Al-Rashood STA; Al-Rashood KA; Eladwy RA; Al-Dhfyan A; Kabil MM; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):986-991. PubMed ID: 28726519
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of novel 1,2,5-trisubstituted benzimidazoles as potential antitumor agents.
Abonia R; Cortés E; Insuasty B; Quiroga J; Nogueras M; Cobo J
Eur J Med Chem; 2011 Sep; 46(9):4062-70. PubMed ID: 21719162
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and antitumor activity of novel benzimidazole-5-carboxylic acid derivatives and their transition metal complexes as topoisomerease II inhibitors.
Galal SA; Hegab KH; Hashem AM; Youssef NS
Eur J Med Chem; 2010 Dec; 45(12):5685-91. PubMed ID: 20884089
[TBL] [Abstract][Full Text] [Related]
59. Anticancer activity of new compounds using benzimidazole as a scaffold.
Rashid M; Husain A; Shaharyar M; Sarafroz M
Anticancer Agents Med Chem; 2014; 14(7):1003-18. PubMed ID: 24827531
[TBL] [Abstract][Full Text] [Related]
60. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
Kadela-Tomanek M; Bębenek E; Chrobak E; Marciniec K; Latocha M; Kuśmierz D; Jastrzębska M; Boryczka S
Eur J Med Chem; 2019 Sep; 177():302-315. PubMed ID: 31158746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
